BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
Provided By PR Newswire
Last update: Feb 11, 2025
NEW YORK, Feb. 11, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to the registration statement for BioAge's initial public offering conducted on September 26, 2024 (the "IPO"), of the important March 10, 2025 lead plaintiff deadline.
Read more at prnewswire.com
